About this Activity
This educational initiative will enable clinicians to effectively address the challenges in the differential diagnosis of adult ADHD and develop practical strategies for its management.

Learning Objectives
By participating in this symposium, learners will be able to:

• Identify confounders that complicate the diagnosis of adult ADHD
  
• Recognize the complexities in the differential diagnosis of adult ADHD
  
• Evaluate the efficacy and safety of nonpharmacologic and pharmacologic treatment options for adult ADHD

Who Will Benefit
This activity was designed to meet the continuing education needs of psychiatrists and other physicians. Other mental health professionals may find this activity informative and should check with their state licensing and certification boards to determine if it meets their continuing education requirements.

Your Distinguished Faculty

	Joel L. Young, MD Medical Director and Founder, Rochester Center for Behavioral Medicine
	Michael A. Schwartz, MD Clinical Professor of Psychiatry, University of Hawaii

Faculty Disclosures
Joel L. Young, MD, is a member of the Speakers Bureau for Cephalon, Inc., Eli Lilly and Company, GlaxoSmithKline, McNeil Consumer Healthcare, Sepracor, Shire Pharmaceuticals, Inc., and Takeda Pharmaceuticals North America, Inc. He receives grants and/or research support from Cephalon, Inc., Eli Lilly and Company, and Novartis Pharmaceuticals Corporation.

Michael A. Schwartz, MD, has been a member of the Speakers Bureau for AstraZeneca, Eli Lilly and Company, Cephalon, Inc., Pfizer Inc., Takeda, and Wyeth Pharmaceuticals.

Commercial Support

Supported by an educational grant from Eli Lilly and Company

Disclaimers
The content of this video activity may include product information that is inconsistent with or outside of the approved labeling for these products in the United States. Before prescribing any medication, you must familiarize yourself with the manufacturer's product information.

To earn continuing education credit, view this online course and complete the posttest and evaluation provided. A passing score of 75% or more must be achieved on the posttest. A link is provided within this online activity to access the posttest and evaluation. You will have the option of printing a CME Certificate for your records after submission of the evaluation.

CME LLC and are not responsible for the speaker's statements, materials, acts or omissions.

Continuing Medical Education
CME LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CME LLC designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Content Originally Presented: 10/31/08; 9:30-10:45pm
Online Date: 12/20/08
Credit Expiration Date: 12/20/09

This activity is based on the symposium Essential Elements in the Diagnosis and Treatment of Adult ADHD: Pathways to Optimized Care on October 30, 2008 in San Diego, CA and may not reflect the most current data. Participants who attended the live symposium mentioned above cannot claim credit for this activity.